Literature DB >> 23686390

Rank-based principal stratum sensitivity analyses.

X Lu1, D V Mehrotra, B E Shepherd.   

Abstract

We describe rank-based approaches to assess principal stratification treatment effects in studies where the outcome of interest is only well-defined in a subgroup selected after randomization. Our methods are sensitivity analyses, in that estimands are identified by fixing a parameter and then we investigate the sensitivity of results by varying this parameter over a range of plausible values. We present three rank-based test statistics and compare their performance through simulations, and provide recommendations. We also study three different bootstrap approaches for determining levels of significance. Finally, we apply our methods to two studies: an HIV vaccine trial and a prostate cancer prevention trial.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  causal inference; monotonicity; non-normality; principal stratification; ranks

Mesh:

Substances:

Year:  2013        PMID: 23686390      PMCID: PMC5753805          DOI: 10.1002/sim.5849

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  22 in total

1.  An estimator for treatment comparisons among survivors in randomized trials.

Authors:  Douglas Hayden; Donna K Pauler; David Schoenfeld
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

2.  Sensitivity analyses comparing outcomes only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine trials.

Authors:  Bryan E Shepherd; Peter B Gilbert; Yannis Jemiai; Andrea Rotnitzky
Journal:  Biometrics       Date:  2006-06       Impact factor: 2.571

3.  Principal stratification designs to estimate input data missing due to death.

Authors:  Constantine E Frangakis; Donald B Rubin; Ming-Wen An; Ellen MacKenzie
Journal:  Biometrics       Date:  2007-09       Impact factor: 2.571

4.  Sensitivity analysis for principal stratum direct effects, with an application to a study of physical activity and coronary heart disease.

Authors:  Arvid Sjölander; Keith Humphreys; Stijn Vansteelandt; Rino Bellocco; Juni Palmgren
Journal:  Biometrics       Date:  2009-06       Impact factor: 2.571

Review 5.  Principal stratification--a goal or a tool?

Authors:  Judea Pearl
Journal:  Int J Biostat       Date:  2011-03-30       Impact factor: 0.968

6.  Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis.

Authors:  Bryan E Shepherd; Mary W Redman; Donna P Ankerst
Journal:  J Am Stat Assoc       Date:  2008-12-01       Impact factor: 5.033

7.  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

Authors:  Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para
Journal:  J Infect Dis       Date:  2005-01-27       Impact factor: 5.226

8.  HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1-infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccine.

Authors:  Peter B Gilbert; Marta L Ackers; Phillip W Berman; Donald P Francis; Vladimir Popovic; Dale J Hu; William L Heyward; Faruk Sinangil; Bryan E Shepherd; Marc Gurwith
Journal:  J Infect Dis       Date:  2005-08-12       Impact factor: 5.226

9.  Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.

Authors:  Mary W Redman; Catherine M Tangen; Phyllis J Goodman; M Scott Lucia; Charles A Coltman; Ian M Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2008-05-18

10.  Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization.

Authors:  Bryan E Shepherd; Peter B Gilbert; Thomas Lumley
Journal:  J Am Stat Assoc       Date:  2007-06       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.